CLSD logo

Clearside Biomedical, Inc. Common Stock


CLSD: Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.


Show CLSD Financials

Consumer Interest
SEC Filings

Recent trades of CLSD by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by CLSD's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of CLSD in WallStreetBets Daily Discussion


Recent insights relating to CLSD

CNBC Recommendations

Recent picks made for CLSD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CLSD

Corporate Flights

Flights by private jets registered to CLSD